Paroxetine hydrochloride.
David Germann, George Ma, Feixue Han, Anna Tikhomirova
Index: Profiles Drug Subst. Excip. Relat. Methodol. 38 , 367-406, (2013)
Full Text: HTML
Abstract
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotonin reuptake inhibitor. Paroxetine is indicated for the treatment of depression, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, and social anxiety disorder. The physicochemical properties, spectroscopic data (1D and 2D NMR, UV, FT-IR, MS, PXRD), stability, methods of preparation and chromatographic methods of analysis of pharmaceutical, and biological samples of paroxetine are documented in this review. Pharmacokinetics, metabolism, and pharmacological effects are also discussed.
Related Compounds
Related Articles:
2013-02-01
[J. Clin. Psychopharmacol. 33(1) , 3-10, (2013)]
Chronic angle-closure glaucoma related to paroxetine treatment.
2013-07-01
[Semin. Ophthalmol. 28(4) , 244-6, (2013)]
Paroxetine (Brisdelle) for hot flashes.
2013-10-28
[Med. Lett. Drugs Ther. 55(1428) , 85-6, (2013)]
FDA Approval of Paroxetine for Menopausal Hot Flushes
2014-05-08
[N. Engl. J. Med. 370(19) , 1777-9, (2014)]
Serotonin and yawning: a potential adverse drug reaction during antidepressant therapy
2013-10-16
[Presse Med. 43(10 Pt 1) , 1135-6, (2014)]